Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2020
Aim of the study is to evaluate the efficacy of up-front atezolizumab/ bevacizumab (Atezo/Bev) followed by on-demand selective transarterial chemoembolization (sdTACE) and of initial synchronous treatment with TACE and Atezo/Bev in the treatment of unresectable HCC patients.
Epistemonikos ID: 1fc6bd7cda20f437bd1859de2a79823fea55de69
First added on: May 07, 2024